These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3561071)

  • 1. [Value of bloodless methods in the study of renal osteodystrophy: comparison with bone histomorphometry].
    González-Posada JM; Torres A; Lorenzo V; Losada M; Maceira B; Hernández Nieto L; Díaz-Flores L
    Med Clin (Barc); 1987 Feb; 88(7):268-73. PubMed ID: 3561071
    [No Abstract]   [Full Text] [Related]  

  • 2. Assessment of renal osteodystrophy following renal transplantation.
    Pierides AM; Ellis HA; Peart KM; Simpson W; Uldall PR; Kerr DN
    Proc Eur Dial Transplant Assoc; 1975; 11():481-7. PubMed ID: 1105559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of early renal osteodystrophy.
    Eke FU; Winterborn MH; Robertson PW
    Child Nephrol Urol; 1988-1989; 9(1-2):33-7. PubMed ID: 3251619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone histomorphometry is still the golden standard for diagnosing renal osteodystrophy.
    Pecovnik Balon B; Bren A
    Clin Nephrol; 2000 Dec; 54(6):463-9. PubMed ID: 11140807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of renal osteodystrophy with unexpected serum intact parathyroid hormone concentrations.
    Meany DL; Jan de Beur SM; Bill MJ; Sokoll LJ
    Clin Chem; 2009 Sep; 55(9):1737-9. PubMed ID: 19717659
    [No Abstract]   [Full Text] [Related]  

  • 6. PTH and bone markers of renal osteodystrophy in predialysis chronic renal failure.
    Coen G; Mazzaferro S; Ballanti P; Bonucci E
    J Endocrinol Invest; 1992; 15(9 Suppl 6):129-33. PubMed ID: 1300330
    [No Abstract]   [Full Text] [Related]  

  • 7. Renal osteodystrophy in children on maintenance haemodialysis.
    Mehls O; Krempien B; Ritz E; Schärer K; Schüler HW
    Proc Eur Dial Transplant Assoc; 1973; 10(0):197-201. PubMed ID: 4802577
    [No Abstract]   [Full Text] [Related]  

  • 8. Value of the new bone classification system for pediatric patients with chronic kidney disease.
    Jorgetti V; Drüeke TB
    Clin J Am Soc Nephrol; 2010 Oct; 5(10):1730-1. PubMed ID: 20876672
    [No Abstract]   [Full Text] [Related]  

  • 9. The treatment of renal osteodystrophy with 1-alpha-hydroxycholecalciferol.
    Junor BJ; Catto GR; Macleod M
    Calcif Tissue Res; 1977 May; 22 Suppl():112-6. PubMed ID: 912512
    [No Abstract]   [Full Text] [Related]  

  • 10. Renal osteodystrophy in course of periodic dialysis for chronic uremia.
    Kim D; Bell NH; Bundesen W; Putong P; Simon NM; Walker C; Del Greco F
    Trans Am Soc Artif Intern Organs; 1968; 14():367-71. PubMed ID: 5701557
    [No Abstract]   [Full Text] [Related]  

  • 11. Parathyroid hormone measurements in hemodialysis patients as assessments of renal osteodystrophy.
    Aubry WM; Sparks JC; Braunstein GD
    Mt Sinai J Med; 1984 Apr; 51(2):132-7. PubMed ID: 6610110
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hormonal markers of early-stage osteitis fibrosa in patients on hemodialysis].
    Persichetti S; Sagliaschi G; Clemenzia G; Angelitti A; Gallo G; Maggi S; Ponzio R; Punzo G; Tozzo C
    Minerva Med; 1992 Nov; 83(11):721-4. PubMed ID: 1461543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Correlations between osteodensitometry and parameters of uremic osteodystrophy].
    Sforzini S; Viganò MR; Beretta P; Rosa M; d'Amico P; Lomuscio G; Paesani R
    Minerva Med; 1985 Mar; 76(9-10):445-8. PubMed ID: 3982703
    [No Abstract]   [Full Text] [Related]  

  • 14. Histological, hormonal, biochemical and radiological evaluation of vit. D therapy in osteodystrophy patients on RDT.
    Brancaccio D; Graziani G; Faccini JM; Banfi G; Pedoja G; Watson L
    J Urol Nephrol (Paris); 1976; 82(4-5):359-62. PubMed ID: 940182
    [No Abstract]   [Full Text] [Related]  

  • 15. Plasma hydroxyproline in renal osteodystrophy.
    Varghese Z; Moorhead JF; Tatler GL; Baillod RA; Wills MR
    Proc Eur Dial Transplant Assoc; 1973; 10(0):187-96. PubMed ID: 4802560
    [No Abstract]   [Full Text] [Related]  

  • 16. 1,25(OH)2D3 and 25-OHD3 in the treatment of renal osteodystrophy: comparison of combined versus 1,25(OH)2D3 administration alone.
    Coen G; Taccone Gallucci M; Bonucci E; Ballanti P; Bianchi AR; Bianchini G; Matteucci MC; Mazzaferro S; Picca S; Taggi F; Cinotti GA; Casciani CU
    Miner Electrolyte Metab; 1983; 9(1):19-27. PubMed ID: 6687749
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of parathyroid hormone assays with bone histomorphometry in renal osteodystrophy.
    Andress DL; Endres DB; Maloney NA; Kopp JB; Coburn JW; Sherrard DJ
    J Clin Endocrinol Metab; 1986 Nov; 63(5):1163-9. PubMed ID: 3760116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histological renal osteodystrophy, and 25 hydroxycholecalciferol and aluminum levels in patients on continuous ambulatory peritoneal dialysis.
    Gokal R; Ramos JM; Ellis HA; Parkinson I; Sweetman V; Dewar J; Ward MK; Kerr DN
    Kidney Int; 1983 Jan; 23(1):15-21. PubMed ID: 6834691
    [No Abstract]   [Full Text] [Related]  

  • 19. [Renal osteodystrophy].
    Schober HC
    Z Urol Nephrol; 1986 Oct; 79(10):595-602. PubMed ID: 3811647
    [No Abstract]   [Full Text] [Related]  

  • 20. Serum hydroxyproline and renal osteodystrophy in patients maintained on haemodialysis.
    Goulding A; McChesney R; Irvine RO; Dixon SR
    N Z Med J; 1974 Dec; 80(530):540-4. PubMed ID: 4615274
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.